Hassan-Zahraee, M., Ye, Z., Xi, L., Baniecki, M. L., Li, X., Hyde, C. L., Zhang, J., Raha, N., Karlsson, F., Quan, J., Ziemek, D., Neelakantan, S., Lepsy, C., Allegretti, J. R., Romatowski, J., Scherl, E. J., Klopocka, M., Danese, S., Chandra, D. E., Schoenbeck, U., Vincent, M. S., Longman, R., & Hung, K. E. (2022). antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis. Inflammatory bowel diseases, 28(3), 434–446. http://access.bl.uk/ark:/81055/vdc_100151266751.0x00001e